The Cardiovascular Research Training Program at Brigham and Women's Hospital aims to prepare trainees for independent careers in investigative pursuits. The three themes of particular focus for this T-32 program include 1) Myocardial Cellular and Molecular Biology and Genetics, 2) Vascular Cell and Molecular Biology, and 3) Translational/Clinical Cardiovascular Research. We propose to strive to continue our record of preparing our trainees to develop independent research programs, obtain faculty positions, and acquire peer-reviewed funding. Our environment offers substantial resources to trainees, ranging from core laboratories within Brigham and Women's Hospital, formal educational opportunities including those of the adjacent Chan-Harvard School of Public Health, and ample resources within the individual laboratories of faculty members. The program provides a structured program for each trainee including formulating formal Individual Development Plans for each trainee, orientation lectures, formal instruction in responsible conduct and professionalism in research, advanced course work, multiple inter-disciplinary research group meetings and seminar series, and tailored and flexible research experiences. Indeed, a historical strength of our T-32 program is working with trainees to place them in the best laboratory and mentoring environment to meet their individual training needs and career goals whether it be at BWH and its partner institution the MGH, or in the broader surrounding environment including the Dana-Farber Cancer Institute, the Harvard Medical School and Chan School of Public Health, The Broad Institute, Children?s Hospital, MIT, the Harvard BioLabs and the Stem Cell Regenerative Biology Institute among others. Each trainee works under the close supervision of a faculty mentor throughout their training. In addition, a Fellowship Advisory Board oversees the program and monitors closely the progress of trainees and their Individual Development Plans. The Research-in-Progress seminar, an annual Fellow's Poster Session, and Cardiovascular Grand Rounds serve to highlight and support the work of the post-doctoral trainees. We have a particular and successful commitment to recruiting and fostering the careers of woman and minority trainees. In this renewal application we propose to continue our longstanding record (documented within) of preparing a talented pool of fellows for successful academic careers.

Public Health Relevance

The Cardiovascular Research Training Program at Brigham and Women's Hospital aims to prepare trainees for independent careers in investigative pursuits. This T-32 focusses on 1) Myocardial Cellular and Molecular Biology and Genetics, 2) Vascular Cell and Molecular Biology, and 3) Translational/Clinical Cardiovascular Research. Our environment offers substantial resources to trainees to ensure continuation of our longstanding record of preparing a talented pool of trainees for productive independent research careers.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL007604-36
Application #
9855765
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Lidman, Karin Fredriksson
Project Start
1985-07-01
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
36
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Vijayakumar, Shilpa; Vaduganathan, Muthiah; Butler, Javed (2018) Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions. Circulation 137:1060-1073
Wadhera, Rishi K; Joynt Maddox, Karen E; Fonarow, Gregg C et al. (2018) Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure. Circ Cardiovasc Qual Outcomes 11:e004729
Golwala, Harsh B; Cannon, Christopher P; Steg, Ph Gabriel et al. (2018) Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials. Eur Heart J 39:1726-1735a
Bergmark, Brian A; Bhatt, Deepak L; Braunwald, Eugene et al. (2018) Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease. Diabetes Care 41:577-585
Vaduganathan, Muthiah; Cheema, Baljash; Cleveland, Erin et al. (2018) Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial. Eur J Heart Fail 20:677-686
Greene, Stephen J; Butler, Javed; Fonarow, Gregg C et al. (2018) Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. Eur J Heart Fail 20:281-291
Vaduganathan, Muthiah; Samman Tahhan, Ayman; Greene, Stephen J et al. (2018) Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years. Eur J Heart Fail 20:1068-1071
Wadhera, Rishi K; Yeh, Robert W; Joynt Maddox, Karen E (2018) The Rise and Fall of Mandatory Cardiac Bundled Payments. JAMA 319:335-336
Carreras, Edward T; Kaneko, Tsuyoshi; Ramirez-Del Val, Fernando et al. (2018) Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement. Catheter Cardiovasc Interv 91:798-805
Vaduganathan, Muthiah; Nagarur, Amulya; Qamar, Arman et al. (2018) Availability and Use of Shared Data From Cardiometabolic Clinical Trials. Circulation 137:938-947

Showing the most recent 10 out of 150 publications